Pharmaceutical major AbbVie Healthcare India Private Limited has failed to secure a complete clinical trial waiver from the ...

SEC asks Abbvie to conduct Phase III study on subcutaneous drug for Parkinson's disease: Our Bureau, New Delhi Friday, July 3, 2026, 08:00 Hrs [IST] A Subject Expert Committee (SE ...

MEMPHIS, Tenn. — An inmate who died while in custody at the Hardeman County Jail this week passed away from natural causes, ...

The Trump administration’s massive deportation agenda sailed ahead on Thursday when the Supreme Court ruled to allow the ...

Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...

Several ASX healthcare companies are tackling neurodegenerative diseases where effective treatments remain limited.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. From Union forces deliberately burning forests and fields during the ...

Cumulus Neuroscience (Cumulus; the Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced the publication ...

Paraquat is one of the world’s most widely used herbicides. It’s also highly toxic and some research points to a link with Parkinson’s disease. Its use is highly restricted in some countries, and ...

A new meta-analysis suggests that CBD may improve emotional behavior and cognition in animal models, but researchers caution ...

The crackdown on scam compounds in Cambodia is leading some gangs to relocate to beach resorts and office buildings in Sri Lanka, in what may be the next phase of one of the world’s fastest-growing ...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...